Long-term evaluation of cervical disc arthroplasty with the Mobi-C© cervical disc: A randomized, prospective, multicenter clinical trial with seven-year follow-up

Kris Radcliff, Reginald J. Davis, Michael S. Hisey, Pierce D. Nunley, Gregory A. Hoffman, Robert J. Jackson, Hyun W. Bae, Todd Albert, Dom Coric

Research output: Contribution to journalArticlepeer-review

Abstract

Background Cervical total disc replacement (TDR) is an increasingly accepted procedure for the treatment of symptomatic cervical degenerative disc disease. Multiple Level I evidence clinical trials have established cervical TDR to be a safe and effective procedure in the short-term. The objective of this study is to provide a long-term assessment of TDR versus anterior discectomy and fusion for the treatment of one- and two-level disc disease. Methods This study was a continuation of a prospective, multicenter, randomized, US FDA IDE clinical trial comparing cervical TDR with the Mobi-C

Original languageEnglish (US)
Pages (from-to)244-262
Number of pages19
JournalInternational Journal of Spine Surgery
Volume11
Issue number4
DOIs
StatePublished - 2017

Keywords

  • ACDF
  • Cervical total disc replacement
  • Degenerative disc disease
  • Mobi-C

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Long-term evaluation of cervical disc arthroplasty with the Mobi-C© cervical disc: A randomized, prospective, multicenter clinical trial with seven-year follow-up'. Together they form a unique fingerprint.

Cite this